Blutt Mitchell J Md

Avg. Two Year Performance

19% Avg. Purchase Return
9% Compound
(58%) Avg. Sale Return
(26%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(< 1%)(3%)7%3%133%
Purchase Success Rate3 of 64 of 65 of 62 of 51 of 1
Average Sale Return(14%)(15%)2%(21%)(58%)
Sale Success Rate0 of 21 of 21 of 20 of 20 of 2
Drugs » Biotechnology

Director:

Holdings: 220.0K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--